Dentsply Sirona Announces Appointment of Janet Vergis as New Board Member
September 25 2019 - 4:05PM
DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental
Solutions Company, today announced that Janet S. Vergis has been
appointed to its Board of Directors, increasing the size of its
Board from ten to eleven members.
“On behalf of Dentsply Sirona and the Board of
Directors, I am pleased to welcome Ms. Vergis to the Board,” said
Eric K. Brandt, Non-Executive Chairman of the Board. “Janet brings
extensive experience in the dental and healthcare industries and a
proven track record of success in research and development and new
product development which complements our Board of Directors’
skills and experiences. We expect Janet will be a valuable member
of our Board and look forward to her contributions as our team
continues to focus on delivering growth.”
About Janet S. Vergis
Ms. Janet S. Vergis has served as an Executive Advisor for
private equity firms since January 2013, where she identifies and
evaluates healthcare investment opportunities. From January 2011 to
August 2012, Ms. Vergis was the Chief Executive Officer of
OraPharma, Inc., a specialty pharmaceutical company dedicated to
oral health, where she led that company’s successful turnaround and
its subsequent sale. From 2004 to 2009, Ms. Vergis served as
President of Janssen Pharmaceuticals, McNeil Pediatrics and
Ortho-McNeil Neurologics. From 1988 to 2004, Ms. Vergis served in
various positions of increasing responsibility in executive
leadership, research and development, new product development,
sales, and marketing with Johnson & Johnson and its
subsidiaries. Ms. Vergis is also currently a member of the
Board of Directors of Church & Dwight Co., Inc. and MedDay
Pharmaceuticals and was a member of the Board of Directors of
Amneal Pharmaceuticals, Inc. from 2015 until 2019. Ms. Vergis
earned a B.S. degree in Biology and an M.S. degree in Physiology
from The Pennsylvania State University.
About Dentsply Sirona
Dentsply Sirona is the world’s largest
manufacturer of professional dental products and technologies, with
a 132-year history of innovation and service to the dental industry
and patients worldwide. Dentsply Sirona develops, manufactures, and
markets a comprehensive solutions offering including dental and
oral health products as well as other consumable medical devices
under a strong portfolio of world class brands. As The Dental
Solutions Company, Dentsply Sirona’s products provide innovative,
high-quality and effective solutions to advance patient care and
deliver better, safer and faster dentistry. The Company’s shares of
common stock are listed in the United States on Nasdaq under the
symbol XRAY. Visit www.dentsplysirona.com for more information
about Dentsply Sirona and its products.
Contact Information:
Investors:John Sweeney, CFA, IRCVice President,
Investor
Relations+1-717-849-7863John.Sweeney@dentsplysirona.com
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Mar 2024 to Apr 2024
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Apr 2023 to Apr 2024